QVT Financial LP
QVT Financial LP is a multi-strategy investment adviser and hedge fund headquartered in New York, NY. Founded in 2003, the firm originally started as a proprietary trading group within an investment bank before becoming an independent adviser. Since 2018, QVT shifted its focus primarily toward investing the capital of its principals and a select group of private investors, operating under a family office model. The firm is known for employing idiosyncratic, fundamental strategies, and leverages internally-developed, proprietary software. QVT serves institutional clients and high-net-worth individuals, with a core team that has worked together for over 15 years.
Investment Strategy
QVT employs a multi-strategy investment approach, focusing on innovative, fundamental, and idiosyncratic trading strategies. It invests across diverse sectors such as biotech & healthcare, energy & shipping, structured finance, opportunistic/litigation, and technology. The firm is recognized for deep expertise in both public and private markets, frequently targeting misunderstood or highly complex securities. QVT's flexible and opportunistic mandate allows for concentrated, longer-horizon positions and the use of activist tactics or litigation financing when appropriate. Proprietary technology and cross-sectoral insight drive its portfolio management.
Latest 13F Filing Activity
QVT Financial LP filed their most recent 13F report on Jun 30, 2025 disclosing 34 equity positions and 9 options positions with a total 13F market value of $1B. The fund increased holdings in Nvidia Corporation, Allot LTD, Goldman Sachs Group Inc. among other positions. QVT Financial LP reduced exposure to Roivant Sciences LTD, MP Materials Corp., Nexstar Media Group Inc. among others.
Top Holdings
Equity Positions (34)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
R ROIV | ROIVANT SCIENCES LTD | 29.50% | $331.1M | 29,381,635 | $10.08 | $11.27 | -$332.7M |
G GS | GOLDMAN SACHS GROUP INC | 4.76% | $53.4M | 75,426 | $288.34 | $707.75 | +$12.5M |
A ALLT | ALLOT LTD | 3.26% | $36.6M | 4,505,793 | $7.39 | $8.55 | +$15.5M |
T TRML | TOURMALINE BIO INC | 3.07% | $34.5M | 2,154,653 | $19.08 | $15.99 | +$12.0M |
E ECO | OKEANIS ECO TANKERS COR | 2.48% | $27.8M | 1,423,997 | $30.10 | $21.73 | -$474.2K |
Options Positions (9)
| Ticker | Security | Action | Type | Notional Value | Contracts | Underlying Price | Premium Paid | Change (Contracts) | Change (Value) |
|---|---|---|---|---|---|---|---|---|---|
H HYG | ISHARES TR | New | Put | $213.7M | 26,500 | $80.65 | $80.65 | +26,500 | +$213.7M |
I IONQ | IONQ INC | Bought | Put | $36.8M | 8,575 | $42.97 | $39.07 | +6,975 | +$33.3M |
Q QQQ | INVESCO QQQ TR | New | Put | $36.8M | 668 | $551.64 | $551.64 | +667.6 | +$36.8M |
C CVNA | CARVANA CO | New | Put | $33.7M | 1,000 | $336.96 | $336.96 | +1,000 | +$33.7M |
G GS | GOLDMAN SACHS GROUP INC | Bought | Put | $33.5M | 474 | $707.75 | $595.34 | +144 | +$15.5M |
Industry Allocation
Investment Team (6)
| Name | Role | Location | |
|---|---|---|---|
B Bing Jiang | Investment Analyst | New York, NY , United States | |
M Mike Deermount | Valuation Analyst | New York, NY , United States | |
W William Wang | Investment Analyst | New York, NY , United States | |
A Alexandre Paré | Investment Analyst | New York, NY , United States | |
 | Investment Analyst | New York, NY , United States | |
 | Partner | New York, NY , United States |
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more